Targeted Oncology15h
Evaluating Agents to Manage Low-Risk Myelodysplastic Syndrome
Saeed Sadeghi, MD, discusses treatment options in low-risk myelodysplastic syndrome at a Case-Based Roundtable event.
Biosimilars Market Size to Hit USD 127.92 Billion by 2032, Growing at a 17.7% CAGR - SNS Insider
Biosimilars Market Poised for Rapid Growth, Driven by Advancements in Therapeutics and Expanding Patient AccessPune, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Global Biosimilars Market Size & Growth Analysis: ...